Highlight any text to annotate

H.R. 8447, the Protecting America from Seasonal and Pandemic Influenza Act of 2026, strengthens the nation's flu and pandemic preparedness through vaccine development, supply chain improvements, and expanded public access to treatments. The bill sets ambitious timelines to deliver pandemic influenza vaccines within 12 weeks of a strain emerging and to develop a universal influenza vaccine within 10 years, while directing the Department of Health and Human Services to establish public-private partnerships strengthening domestic vaccine manufacturing. To increase vaccination rates and treatment access, the bill requires federal initiatives to combat vaccine misinformation, expand test-to-treat programs in vulnerable communities, and ensure adequate stockpiling and distribution of antivirals and diagnostics for high-risk populations and healthcare workers. The legislation authorizes $335 million annually through fiscal year 2031 for pandemic preparedness activities, plus approximately $3.45 billion annually beginning in fiscal year 2027 for related federal health agency programs including vaccine research, disease surveillance, and hospital preparedness. The bill also creates a streamlined budget process allowing the CDC, NIH, and other health agencies to submit pandemic preparedness requests directly to the President for congressional designation outside normal budget constraints.

Add a comment

Sign in to comment on this bill.

Annotate the text

Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.